Medication and behavior modification

Behavior medication, which veterinarians call behavioral pharmacotherapy, is the use of prescription drugs to change the emotional state behind a behavior problem. Merck's Veterinary Manual says these drugs can help restore a more stable emotional state and improve trainability, and that new patterns of behavior are only established with behavior modification running alongside. The goal is a dog calm enough to learn from what happens to it, not a dog too drowsy to notice.

There are two broad kinds. Baseline medications, such as the SSRIs and tricyclic antidepressants, are given every day, and Merck notes that some take weeks to reach their full effect. Situational medications work quickly and briefly. For separation distress Merck lists trazodone, gabapentin, clonidine and alprazolam, which take effect in about 90 minutes and last 4 to 6 hours, and it describes rapid-onset drugs as an option when a fear trigger is predictable, such as a storm.

Medication and a training stay interact in three ways. Timing: a dog starting a new baseline drug may still be weeks from full effect, so a stay booked in that window meets a dog in transition, and your vet should help set the dates. Observation: a new building tests any treatment plan, and notes on appetite, rest and recovery are useful to the prescriber. Continuity: whatever the dog takes at home has to be given exactly as prescribed while it is away.

How medications are handled during a Dogtown board and train, including timing and storage, is confirmed at the consult, case by case, before any stay is booked. Bring the full list with doses and the prescribing vet's details. If medication is part of a plan for fear or anxiety, Gabriella Pope may recommend an owner-present program instead of a stay, such as Brave & Balanced, Focus & Flow or React Less, Relax More, so the behavior work happens where the dog lives.

For separation anxiety, Merck notes that fluoxetine, an SSRI, and clomipramine, a tricyclic antidepressant, are approved by the FDA in the United States for dogs, and that both have been shown to reduce signs, especially when combined with behavior modification. VCA's veterinary behaviorists, Debra Horwitz and Gary Landsberg, add that tranquilizers alone do not reduce a dog's anxiety, that most dogs do best on one of those two drugs over several months, and that retraining is what builds independence.

The ASPCA's 2022 report on extremely fearful shelter dogs shows the partnership at scale. At its first site almost every dog needed psychotropic medication by eight weeks of treatment, so the program began medication alongside behavior modification from the start, with doses set by a veterinary behaviorist and a two- to three-week weaning schedule before graduation; very few dogs regressed during weaning. The AVSAB adds that vets should not treat medication as a last resort. We found no studies of medication within board and train programs.